Jupiter Neurosciences annual return on equity
2025
Jupiter Neurosciences Return on Equity (ROE) Growth & History (JUNS)
Jupiter Neurosciences's return on equity was −738.83% for fiscal 2025.
View full Jupiter Neurosciences company overviewJupiter Neurosciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −738.83% | — |
Jupiter Neurosciences quarterly return on equity
Q1.25
Q2.25
Q3.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | −327.44% | — |
| Q2 2025 | 2025-06-30 | −102.30% | — |
| Q1 2025 | 2025-03-31 | −42.25% | — |
Jupiter Neurosciences return on equity trends
The latest reported quarter, Q3 2025, shows −327.44%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jupiter Neurosciences source filings ↗